PRPH
ProPhase Labs, Inc.
Price Chart
Latest Quote
$0.08
+0.00 (+0.00%)
Current Price
| Previous Close | $0.08 |
| Open | $0.07 |
| Day High | $0.07 |
| Day Low | $0.07 |
| Volume | 10,221 |
Stock Information
| Shares Outstanding | 14.02M |
| Total Debt | $8.62M |
| Cash Equivalents | $90K |
| Revenue | $4.34M |
| Net Income | $-23.39M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $1.12M |
| EPS (TTM) | $-2.75 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $9.61M |
| Sales | $4.34M |
| Income | $-23.39M |
| Book/sh | $0.55 |
| Cash/sh | $0.01 |
| Employees | 19 |
Financial Ratios
| Quick Ratio | 0.03 |
| Current Ratio | 0.06 |
| Debt/Eq | 245.67 |
Returns & Margins
| ROA | -18.33% |
| ROE | -430.66% |
| Gross Margin | 31.85% |
| Operating Margin | -730.36% |
Ownership
| Insider Ownership | 2.37% |
| Institutional Ownership | 0.07% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 0.17 |
| P/S | 0.26 |
| P/B | 0.15 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.10 |
| SMA50 | $0.11 |
| SMA200 | $1.41 |
| RSI | 41.67 |
| ATR | 0.0207 |
| Shares Float | 13.68M |
| Short Float | 0.71% |
| Short Ratio | 0.08 |
| Volatility | 0.07 |
| Rel Volume | 0.25 |
Performance History
| Week | -11.11% |
| Month | -20.00% |
| Quarter | +0.00% |
| 6 Months | -93.33% |
| YTD | -77.78% |
| Year | -97.71% |
| 3 Years | -99.89% |
| 5 Years | -99.86% |
| 10 Years | -98.93% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.08 | 14,800 |
| 2026-06-17 | $0.08 | 144,500 |
| 2026-06-16 | $0.08 | 10,700 |
| 2026-06-15 | $0.09 | 15,000 |
| 2026-06-12 | $0.08 | 164,500 |
| 2026-06-11 | $0.09 | 30,100 |
| 2026-06-10 | $0.10 | 55,400 |
| 2026-06-09 | $0.10 | 2,700 |
| 2026-06-08 | $0.10 | 16,000 |
| 2026-06-05 | $0.11 | 68,500 |
| 2026-06-04 | $0.13 | 130,800 |
| 2026-06-03 | $0.14 | 69,000 |
| 2026-06-02 | $0.14 | 283,700 |
| 2026-06-01 | $0.12 | 63,100 |
| 2026-05-29 | $0.10 | 64,300 |
| 2026-05-28 | $0.10 | 16,600 |
| 2026-05-27 | $0.10 | 7,500 |
| 2026-05-26 | $0.09 | 4,900 |
| 2026-05-22 | $0.11 | 4,400 |
| 2026-05-21 | $0.09 | 4,200 |
| 2026-05-20 | $0.10 | 1,300 |
| 2026-05-19 | $0.10 | 46,000 |
About ProPhase Labs, Inc.
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart Esophageal Pre-Cancer diagnostics screening test for early detection of esophageal cancer; genomics testing technologies to analyze entire genomes, including the genes and chromosomes in deoxyribonucleic acid; DNA Expand, a platform that allows consumers to upload their DNA data from previous DNA tests obtained from other service providers; and LB-1 and LB-2 for the treatment of cancer, inflammatory diseases or symptoms and memory related syndromes, diseases or symptoms, including dementia and Alzheimer's disease. In addition, the company provides Nebula focuses on genomics testing technologies a comprehensive method for analyzing entire genomes, including the genes and chromosomes in deoxyribonucleic acid (DNA). It offers its genome sequencing products to consumers online with plans to sell in food, drug, and mass retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Uniondale, New York.
đ° Latest News
BC-Most Active Stocks
Associated Press Finance âĸ 2025-12-19T15:30:17ZProPhase Labs, Advanced Biological Laboratories Sign Letter of Intent for Reverse Merger
MT Newswires âĸ 2025-12-19T13:51:47ZProPhase Labs Inc (PRPH) Q3 2025 Earnings Call Highlights: Strategic Initiatives and Financial ...
GuruFocus.com âĸ 2025-11-27T01:01:03Z
ProPhase Labs, Inc. Q3 2025 Earnings Call Summary
Moby âĸ 2025-11-20T13:30:00Z
Critical Biotech giant files Chapter 11 for 3 COVID labs, eyes Bitcoin treasury as lifeline
TheStreet âĸ 2025-09-23T17:41:14Z
ProPhase Labs Inc (PRPH) Q2 2025 Earnings Call Highlights: Strategic Moves and Future Prospects
GuruFocus.com âĸ 2025-08-15T17:00:59Z
Journey Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue Estimates
Zacks âĸ 2025-08-12T21:15:01Z
Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates
Zacks âĸ 2025-08-07T12:25:03Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $6,920,000 | $19,428,000 | $51,993,000 | $37,054,000 |
| Cost Of Revenue | $6,920,000 | $19,428,000 | $51,993,000 | $37,054,000 |
| Total Revenue | $6,770,000 | $34,984,000 | $122,647,000 | $79,042,000 |
| Operating Revenue | $6,770,000 | $34,984,000 | $122,647,000 | $79,042,000 |
| Expenses | ||||
| Interest Expense | $3,350,000 | $1,266,000 | $764,000 | $1,148,000 |
| Total Expenses | $45,399,000 | $56,204,000 | $99,052,000 | $69,241,000 |
| Other Income Expense | $-351,000 | $10,000 | $-76,000 | $-3,990,000 |
| Other Non Operating Income Expenses | $-18,000 | $10,000 | - | - |
| Net Non Operating Interest Income Expense | $-3,350,000 | $-1,188,000 | $-611,000 | $-506,000 |
| Interest Expense Non Operating | $3,350,000 | $1,266,000 | $764,000 | $1,148,000 |
| Operating Expense | $38,479,000 | $36,776,000 | $47,059,000 | $32,187,000 |
| General And Administrative Expense | $37,885,000 | $33,442,000 | $34,385,000 | $22,493,000 |
| Other Operating Expenses | - | $1,932,000 | $12,022,000 | $9,174,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-49,525,000 | $-16,380,000 | $18,463,000 | $6,273,000 |
| Net Interest Income | $-3,350,000 | $-1,188,000 | $-611,000 | $-506,000 |
| Interest Income | $0 | $78,000 | $153,000 | $642,000 |
| Normalized Income | $-49,261,930 | $-16,380,000 | $18,524,253 | $9,185,700 |
| Net Income From Continuing And Discontinued Operation | $-53,364,000 | $-16,782,000 | $18,463,000 | $6,273,000 |
| Total Operating Income As Reported | $-38,629,000 | $-21,220,000 | $23,595,000 | $9,801,000 |
| Net Income Common Stockholders | $-53,364,000 | $-16,782,000 | $18,463,000 | $6,273,000 |
| Net Income | $-53,364,000 | $-16,782,000 | $18,463,000 | $6,273,000 |
| Net Income Including Noncontrolling Interests | $-53,364,000 | $-16,782,000 | $18,463,000 | $6,273,000 |
| Net Income Discontinuous Operations | $-3,839,000 | $-402,000 | - | $0 |
| Net Income Continuous Operations | $-49,525,000 | $-16,380,000 | $18,463,000 | $6,273,000 |
| Pretax Income | $-42,330,000 | $-22,398,000 | $22,908,000 | $5,305,000 |
| Special Income Charges | $-333,000 | $0 | $0 | $-3,750,000 |
| Interest Income Non Operating | $0 | $78,000 | $153,000 | $642,000 |
| Operating Income | $-38,629,000 | $-21,220,000 | $23,595,000 | $9,801,000 |
| Gross Profit | $-150,000 | $15,556,000 | $70,654,000 | $41,988,000 |
| Average Dilution Earnings | - | $0 | $632,000 | $1,000,000 |
| Per Share | ||||
| Diluted EPS | $-26.10 | $-9.80 | $10.20 | $4.00 |
| Basic EPS | $-26.10 | $-9.80 | $11.70 | $4.10 |
| Other | ||||
| Tax Effect Of Unusual Items | $-69,930 | $0 | $-14,747 | $-1,077,300 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-32,003,000 | $-14,661,000 | $28,809,000 | $14,006,000 |
| Total Unusual Items | $-333,000 | $0 | $-76,000 | $-3,990,000 |
| Total Unusual Items Excluding Goodwill | $-333,000 | $0 | $-76,000 | $-3,990,000 |
| Reconciled Depreciation | $6,644,000 | $6,471,000 | $5,061,000 | $3,563,000 |
| EBITDA (Bullshit earnings) | $-32,336,000 | $-14,661,000 | $28,733,000 | $10,016,000 |
| EBIT | $-38,980,000 | $-21,132,000 | $23,672,000 | $6,453,000 |
| Diluted Average Shares | $2,987,402 | $1,720,700 | $1,865,100 | $1,839,300 |
| Basic Average Shares | $2,987,402 | $1,720,700 | $1,584,500 | $1,517,200 |
| Diluted NI Availto Com Stockholders | $-53,364,000 | $-16,782,000 | $19,095,000 | $7,273,000 |
| Tax Provision | $7,195,000 | $-6,018,000 | $4,445,000 | $-968,000 |
| Other Special Charges | $333,000 | - | - | - |
| Research And Development | $594,000 | $1,402,000 | $652,000 | $520,000 |
| Selling General And Administration | $37,885,000 | $33,442,000 | $34,385,000 | $22,493,000 |
| Other Gand A | $37,885,000 | $33,442,000 | $34,385,000 | $22,493,000 |
| Write Off | - | - | $0 | $3,750,000 |
| Gain On Sale Of Security | - | - | $-76,000 | $-240,000 |
| Gain On Sale Of Ppe | - | - | - | $0 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-7,628,000 | $31,819,000 | $49,447,000 | $42,067,000 |
| Total Assets | $63,200,000 | $91,927,000 | $87,648,000 | $89,295,000 |
| Total Non Current Assets | $32,563,000 | $44,342,000 | $26,815,000 | $27,978,000 |
| Other Non Current Assets | $5,749,000 | $3,731,000 | $1,163,000 | $608,000 |
| Non Current Prepaid Assets | $217,000 | $832,000 | $121,000 | $460,000 |
| Non Current Deferred Assets | $0 | $7,313,000 | $0 | - |
| Non Current Deferred Taxes Assets | $0 | $7,313,000 | $0 | - |
| Goodwill And Other Intangible Assets | $14,981,000 | $17,564,000 | $14,184,000 | $16,561,000 |
| Other Intangible Assets | $9,750,000 | $12,333,000 | $8,475,000 | $10,852,000 |
| Current Assets | $30,637,000 | $47,585,000 | $60,833,000 | $61,317,000 |
| Other Current Assets | $2,615,000 | $1,955,000 | $2,366,000 | $1,496,000 |
| Assets Held For Sale Current | $6,143,000 | $2,789,000 | - | - |
| Inventory | $1,143,000 | $2,291,000 | $3,976,000 | $4,600,000 |
| Receivables | $20,058,000 | $35,814,000 | $37,054,000 | $37,708,000 |
| Receivables Adjustments Allowances | $-14,843,000 | $-3,864,000 | $-3,140,000 | $-3,901,000 |
| Accounts Receivable | $34,901,000 | $39,678,000 | $37,568,000 | $18,520,000 |
| Cash Cash Equivalents And Short Term Investments | $678,000 | $4,736,000 | $17,437,000 | $17,263,000 |
| Cash And Cash Equivalents | $678,000 | $1,609,000 | $9,109,000 | $8,408,000 |
| Restricted Cash | - | $540,000 | $0 | $250,000 |
| Other Receivables | - | - | $2,626,000 | $23,089,000 |
| Non Current Note Receivables | - | - | - | $0 |
| Prepaid Assets | - | - | - | $1,496,000 |
| Debt | ||||
| Net Debt | $14,181,000 | $5,725,000 | - | $1,632,000 |
| Total Debt | $24,573,000 | $18,456,000 | $6,960,000 | $14,901,000 |
| Long Term Debt And Capital Lease Obligation | $18,005,000 | $15,663,000 | $6,659,000 | $14,238,000 |
| Long Term Debt | $11,652,000 | $7,334,000 | $2,400,000 | $10,040,000 |
| Current Debt And Capital Lease Obligation | $6,568,000 | $2,793,000 | $301,000 | $663,000 |
| Current Debt | $3,207,000 | - | - | - |
| Other Current Borrowings | $3,207,000 | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $55,847,000 | $42,544,000 | $24,017,000 | $30,667,000 |
| Total Non Current Liabilities Net Minority Interest | $23,713,000 | $21,687,000 | $7,942,000 | $15,143,000 |
| Liabilities Heldfor Sale Non Current | $2,924,000 | $2,924,000 | - | - |
| Tradeand Other Payables Non Current | $2,000,000 | $2,000,000 | $0 | - |
| Non Current Deferred Liabilities | $784,000 | $1,100,000 | $1,283,000 | $905,000 |
| Current Liabilities | $32,134,000 | $20,857,000 | $16,075,000 | $15,524,000 |
| Other Current Liabilities | $5,867,000 | $835,000 | - | - |
| Current Deferred Liabilities | $1,698,000 | $2,382,000 | $2,499,000 | $2,034,000 |
| Payables And Accrued Expenses | $17,938,000 | $13,814,000 | $13,225,000 | $12,767,000 |
| Payables | $15,704,000 | $11,923,000 | $10,095,000 | $8,338,000 |
| Total Tax Payable | $1,987,000 | $3,279,000 | $4,190,000 | $1,312,000 |
| Income Tax Payable | $1,987,000 | $3,279,000 | $4,190,000 | $1,312,000 |
| Accounts Payable | $13,717,000 | $8,644,000 | $5,905,000 | $7,026,000 |
| Non Current Deferred Taxes Liabilities | - | $0 | $224,000 | $0 |
| Equity | ||||
| Common Stock Equity | $7,353,000 | $49,383,000 | $63,631,000 | $58,628,000 |
| Total Equity Gross Minority Interest | $7,353,000 | $49,383,000 | $63,631,000 | $58,628,000 |
| Stockholders Equity | $7,353,000 | $49,383,000 | $63,631,000 | $58,628,000 |
| Gains Losses Not Affecting Retained Earnings | $-198,000 | $-300,000 | $757,000 | $-175,000 |
| Other Equity Adjustments | $-198,000 | $-300,000 | $757,000 | $-175,000 |
| Retained Earnings | $-58,393,000 | $-5,029,000 | $11,753,000 | $2,642,000 |
| Other | ||||
| Treasury Shares Number | $1,294,096 | $1,894,096 | $1,812,697 | $1,681,884 |
| Ordinary Shares Number | $2,987,402 | $1,804,502 | $1,621,077 | $1,548,590 |
| Share Issued | $4,281,498 | $3,698,598 | $3,433,774 | $3,230,474 |
| Tangible Book Value | $-7,628,000 | $31,819,000 | $49,447,000 | $42,067,000 |
| Invested Capital | $22,212,000 | $56,717,000 | $66,031,000 | $68,668,000 |
| Working Capital | $-1,497,000 | $26,728,000 | $44,758,000 | $45,793,000 |
| Capital Lease Obligations | $9,714,000 | $11,122,000 | $4,560,000 | $4,861,000 |
| Total Capitalization | $19,005,000 | $56,717,000 | $66,031,000 | $68,668,000 |
| Treasury Stock | $64,000,000 | $64,000,000 | $58,033,000 | $48,407,000 |
| Additional Paid In Capital | $129,921,000 | $118,694,000 | $109,138,000 | $104,552,000 |
| Capital Stock | $23,000 | $18,000 | $16,000 | $16,000 |
| Common Stock | $23,000 | $18,000 | $16,000 | $16,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $784,000 | $1,100,000 | $1,059,000 | $905,000 |
| Long Term Capital Lease Obligation | $6,353,000 | $8,329,000 | $4,259,000 | $4,198,000 |
| Current Deferred Revenue | $1,698,000 | $2,382,000 | $2,499,000 | $2,034,000 |
| Current Capital Lease Obligation | $3,361,000 | $2,793,000 | $301,000 | $663,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $63,000 | $1,033,000 | $50,000 | $60,000 |
| Current Accrued Expenses | $2,234,000 | $1,891,000 | $3,130,000 | $4,429,000 |
| Goodwill | $5,231,000 | $5,231,000 | $5,709,000 | $5,709,000 |
| Net PPE | $11,616,000 | $14,902,000 | $11,347,000 | $10,349,000 |
| Accumulated Depreciation | $-8,980,000 | $-6,099,000 | $-8,440,000 | $-6,883,000 |
| Gross PPE | $20,596,000 | $21,001,000 | $19,787,000 | $17,232,000 |
| Leases | $1,241,000 | $374,000 | $0 | - |
| Other Properties | $15,928,000 | $17,239,000 | $9,847,000 | $8,732,000 |
| Machinery Furniture Equipment | $3,427,000 | $3,388,000 | $7,859,000 | $6,419,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-8,000 | $-219,000 | $-512,000 | $-435,000 |
| Finished Goods | $375,000 | $1,320,000 | $356,000 | $272,000 |
| Work In Process | $65,000 | $119,000 | $754,000 | $260,000 |
| Raw Materials | $711,000 | $1,071,000 | $3,378,000 | $4,503,000 |
| Other Short Term Investments | $0 | $3,127,000 | $8,328,000 | $8,855,000 |
| Buildings And Improvements | - | $1,746,000 | $1,729,000 | $1,729,000 |
| Land And Improvements | - | $352,000 | $352,000 | $352,000 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-18,444,000 | $-13,972,000 | $24,632,000 | $-17,850,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-17,538,000 | $-11,888,000 | $28,551,000 | $-13,619,000 |
| Cash From Discontinued Operating Activities | $-5,735,000 | $305,000 | - | - |
| Cash Flow From Continuing Operating Activities | $-11,803,000 | $-12,193,000 | $28,551,000 | $-13,619,000 |
| Operating Gains Losses | $260,000 | $-45,000 | $227,000 | $165,000 |
| Investing Activities | ||||
| Capital Expenditure | $-906,000 | $-2,084,000 | $-3,919,000 | $-4,231,000 |
| Investing Cash Flow | $2,422,000 | $-1,369,000 | $-2,077,000 | $-19,666,000 |
| Cash From Discontinued Investing Activities | $-275,000 | $-1,071,000 | - | - |
| Cash Flow From Continuing Investing Activities | $2,697,000 | $-298,000 | $-2,077,000 | $-19,666,000 |
| Capital Expenditure Reported | $-906,000 | $-2,084,000 | $-3,919,000 | $-4,231,000 |
| Net Other Investing Changes | - | $478,000 | - | $-700,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $0 | $-5,967,000 | $-9,626,000 | $-917,000 |
| Issuance Of Capital Stock | $7,594,000 | $0 | $0 | $40,635,000 |
| Financing Cash Flow | $14,185,000 | $5,757,000 | $-26,023,000 | $35,127,000 |
| Cash From Discontinued Financing Activities | $978,000 | $2,924,000 | - | - |
| Cash Flow From Continuing Financing Activities | $13,207,000 | $2,833,000 | $-26,023,000 | $35,127,000 |
| Net Common Stock Issuance | $7,594,000 | $-5,967,000 | $-9,626,000 | $39,718,000 |
| Common Stock Issuance | $7,594,000 | $0 | $0 | $40,635,000 |
| Cash Dividends Paid | - | $0 | $-9,353,000 | $-4,546,000 |
| Common Stock Dividend Paid | - | $0 | $-9,353,000 | $-4,546,000 |
| Other | ||||
| Repayment Of Debt | $-4,249,000 | $0 | $-7,044,000 | $-45,000 |
| Issuance Of Debt | $9,862,000 | $7,600,000 | $0 | $0 |
| Interest Paid Supplemental Data | $3,105,000 | $932,000 | $763,000 | $1,000,000 |
| Income Tax Paid Supplemental Data | $1,126,000 | $3,000,000 | $1,696,000 | $0 |
| End Cash Position | $678,000 | $1,609,000 | $9,109,000 | $8,658,000 |
| Beginning Cash Position | $1,609,000 | $9,109,000 | $8,658,000 | $6,816,000 |
| Changes In Cash | $-931,000 | $-7,500,000 | $451,000 | $1,842,000 |
| Proceeds From Stock Option Exercised | $0 | $1,200,000 | $0 | - |
| Common Stock Payments | $0 | $-5,967,000 | $-9,626,000 | $-917,000 |
| Net Issuance Payments Of Debt | $5,613,000 | $7,600,000 | $-7,044,000 | $-45,000 |
| Net Long Term Debt Issuance | $5,613,000 | $7,600,000 | $-7,044,000 | $-45,000 |
| Long Term Debt Payments | $-4,249,000 | $0 | $-7,044,000 | $-45,000 |
| Long Term Debt Issuance | $9,862,000 | $7,600,000 | $0 | $0 |
| Net Investment Purchase And Sale | $3,374,000 | $4,166,000 | $1,390,000 | $-5,669,000 |
| Sale Of Investment | $3,374,000 | $7,985,000 | $8,167,000 | $15,858,000 |
| Purchase Of Investment | $0 | $-3,819,000 | $-6,777,000 | $-21,527,000 |
| Net Business Purchase And Sale | $0 | $-2,426,000 | $0 | $-9,066,000 |
| Sale Of Business | $0 | $478,000 | - | - |
| Purchase Of Business | $0 | $-2,904,000 | $0 | $-9,066,000 |
| Net PPE Purchase And Sale | $229,000 | $46,000 | $452,000 | $0 |
| Sale Of PPE | $229,000 | $46,000 | $452,000 | $0 |
| Change In Working Capital | $14,889,000 | $-6,722,000 | $-4,340,000 | $-34,615,000 |
| Change In Other Working Capital | $6,150,000 | $-7,696,000 | $481,000 | $2,608,000 |
| Change In Other Current Liabilities | $-1,785,000 | $456,000 | $-724,000 | $-2,697,000 |
| Change In Other Current Assets | $853,000 | $0 | $-555,000 | $-368,000 |
| Change In Payables And Accrued Expense | $3,618,000 | $1,181,000 | $871,000 | $4,340,000 |
| Change In Accrued Expense | $-156,000 | $-770,000 | $-886,000 | $1,890,000 |
| Change In Payable | $3,774,000 | $1,951,000 | $1,757,000 | $2,450,000 |
| Change In Account Payable | $5,066,000 | $2,862,000 | $-1,121,000 | $2,450,000 |
| Change In Tax Payable | $-1,292,000 | $-911,000 | $2,878,000 | - |
| Change In Income Tax Payable | $-1,292,000 | $-911,000 | $2,878,000 | - |
| Change In Prepaid Assets | $-45,000 | $-216,000 | $-617,000 | $1,445,000 |
| Change In Inventory | $1,360,000 | $170,000 | $702,000 | $-1,746,000 |
| Change In Receivables | $4,738,000 | $-617,000 | $-4,498,000 | $-38,197,000 |
| Changes In Account Receivables | $4,738,000 | $-617,000 | $-4,498,000 | $-38,197,000 |
| Other Non Cash Items | $1,485,000 | $132,000 | $4,000 | $-311,000 |
| Stock Based Compensation | $3,638,000 | $3,536,000 | $3,986,000 | $3,183,000 |
| Provisionand Write Offof Assets | $10,806,000 | $724,000 | $-839,000 | $4,133,000 |
| Asset Impairment Charge | $0 | $91,000 | $6,163,000 | $3,750,000 |
| Depreciation Amortization Depletion | $6,644,000 | $6,471,000 | $5,061,000 | $3,563,000 |
| Depreciation And Amortization | $6,644,000 | $6,471,000 | $5,061,000 | $3,563,000 |
| Depreciation | $6,644,000 | $6,471,000 | $5,061,000 | $3,563,000 |
| Gain Loss On Investment Securities | $18,000 | $-22,000 | $354,000 | $165,000 |
| Gain Loss On Sale Of PPE | $-91,000 | $-23,000 | - | $0 |
| Net Income From Continuing Operations | $-49,525,000 | $-16,380,000 | $18,463,000 | $6,273,000 |
| Unrealized Gain Loss On Investment Securities | - | $0 | $-174,000 | $240,000 |
Fetched: 2026-02-02